Chenglong Liu - Search Results

Year	Number of Results
2002	3
2003	2
2004	2
2005	1
2006	3
2007	2
2008	2
2009	3
2010	6
2011	9
2012	14
2013	9
2014	11
2015	6
2016	9
2017	9
2018	9
2019	12
2020	14
2021	16
2022	14

1

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.

Zhang Y, Song J, Zhao Z, Yang M, Chen M, Liu C, Ji J, Zhu D. Zhang Y, et al. Among authors: liu c. Cancer Lett. 2020 Feb 1;470:84-94. doi: 10.1016/j.canlet.2019.10.016. Epub 2019 Oct 11. Cancer Lett. 2020. PMID: 31610266

2

IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.

Hu B, Yu M, Ma X, Sun J, Liu C, Wang C, Wu S, Fu P, Yang Z, He Y, Zhu Y, Huang C, Yang X, Shi Y, Qiu S, Sun H, Zhu AX, Zhou J, Xu Y, Zhu D, Fan J. Hu B, et al. Among authors: liu c. Cancer Discov. 2022 Jul 6;12(7):1718-1741. doi: 10.1158/2159-8290.CD-21-1022. Cancer Discov. 2022. PMID: 35412588

3

BCL9 regulates CD226 and CD96 checkpoints in CD8⁺ T cells to improve PD-1 response in cancer.

Feng M, Wu Z, Zhou Y, Wei Z, Tian E, Mei S, Zhu Y, Liu C, He F, Li H, Xie C, Jin J, Dong J, Yang D, Yu K, Qian J, Lambrechts D, Wang MW, Zhu D. Feng M, et al. Among authors: liu c. Signal Transduct Target Ther. 2021 Aug 20;6(1):313. doi: 10.1038/s41392-021-00730-0. Signal Transduct Target Ther. 2021. PMID: 34417435 Free PMC article.

4

Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors.

Zhang H, Bao Y, Liu C, Li J, Zhu D, Zhang Q. Zhang H, et al. Among authors: liu c. Future Med Chem. 2021 May;13(10):927-940. doi: 10.4155/fmc-2020-0357. Epub 2021 Apr 14. Future Med Chem. 2021. PMID: 33849283 Review.

5

Mimicking Nature's Butterflies: Electrochromic Devices with Dual-Sided Differential Colorations.

Chen J, Wang Z, Liu C, Chen Z, Tang X, Wu Q, Zhang S, Song G, Cong S, Chen Q, Zhao Z. Chen J, et al. Among authors: liu c. Adv Mater. 2021 Apr;33(14):e2007314. doi: 10.1002/adma.202007314. Epub 2021 Feb 26. Adv Mater. 2021. PMID: 33634919

6

Protein ADP-Ribosylation Takes Control in Plant-Bacterium Interactions.

Feng B, Liu C, Shan L, He P. Feng B, et al. Among authors: liu c. PLoS Pathog. 2016 Dec 1;12(12):e1005941. doi: 10.1371/journal.ppat.1005941. eCollection 2016 Dec. PLoS Pathog. 2016. PMID: 27907213 Free PMC article. Review. No abstract available.

7

Reactive wear protection through strong and deformable oxide nanocomposite surfaces.

Liu C, Li Z, Lu W, Bao Y, Xia W, Wu X, Zhao H, Gault B, Liu C, Herbig M, Fischer A, Dehm G, Wu G, Raabe D. Liu C, et al. Nat Commun. 2021 Sep 17;12(1):5518. doi: 10.1038/s41467-021-25778-y. Nat Commun. 2021. PMID: 34535645 Free PMC article.

8

Correction: Liu, C., et al. A Novel System for Correction of Relative Angular Displacement between Airborne Platform and UAV in Target Localization. Sensors 2017, 17, 510.

Liu C, Liu J, Song Y, Liang H. Liu C, et al. Sensors (Basel). 2019 Aug 21;19(17):3639. doi: 10.3390/s19173639. Sensors (Basel). 2019. PMID: 31438547 Free PMC article.

9

Electrochromic Metamaterials of Metal-Dielectric Stacks for Multicolor Displays with High Color Purity.

Wu Q, Wang X, Sun P, Wang Z, Chen J, Chen Z, Song G, Liu C, Mu X, Cong S, Zhao Z. Wu Q, et al. Among authors: liu c. Nano Lett. 2021 Aug 25;21(16):6891-6897. doi: 10.1021/acs.nanolett.1c02030. Epub 2021 Aug 6. Nano Lett. 2021. PMID: 34355916

10

Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.

Liu C, von Brunn A, Zhu D. Liu C, et al. Med Drug Discov. 2020 Sep;7:100056. doi: 10.1016/j.medidd.2020.100056. Epub 2020 Jul 16. Med Drug Discov. 2020. PMID: 32835213 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results